GR930300021T1 - - Google Patents

Info

Publication number
GR930300021T1
GR930300021T1 GR930300021T GR930300021T GR930300021T1 GR 930300021 T1 GR930300021 T1 GR 930300021T1 GR 930300021 T GR930300021 T GR 930300021T GR 930300021 T GR930300021 T GR 930300021T GR 930300021 T1 GR930300021 T1 GR 930300021T1
Authority
GR
Greece
Application number
GR930300021T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR930300021T1 publication Critical patent/GR930300021T1/el

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR930300021T 1990-07-13 1993-04-28 GR930300021T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02094490A IT1243342B (it) 1990-07-13 1990-07-13 Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria

Publications (1)

Publication Number Publication Date
GR930300021T1 true GR930300021T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-04-28

Family

ID=11174427

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930300021T GR930300021T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-07-13 1993-04-28

Country Status (7)

Country Link
EP (1) EP0491897A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU8093591A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2066731A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2034926T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR930300021T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1243342B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1992000725A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552160A (en) * 1991-01-25 1996-09-03 Nanosystems L.L.C. Surface modified NSAID nanoparticles
DK0644755T3 (da) * 1992-06-10 1997-09-22 Nanosystems Llc Overflademodificerede NSAID-nanopartikler
JPH07506839A (ja) * 1992-12-04 1995-07-27 メイヤー・ファーマシューティカル・ラボラトリース・インコーポレーテッド スプレー可能な鎮痛剤組成物およびその使用方法
US5702724A (en) * 1993-06-08 1997-12-30 Ciba-Geigy Corporation Process for the preparation of an oral solid dosage form containing diclofenac
KR100304064B1 (ko) * 1993-08-12 2001-11-22 다카하시 미치나오 구강용조성물
GB9318880D0 (en) * 1993-09-11 1993-10-27 Smithkline Beecham Plc Pharmaceutical composition
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
EP0839029A1 (en) * 1995-07-20 1998-05-06 PHARMACIA & UPJOHN COMPANY Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
HUP9600758A2 (en) * 1996-03-27 1998-03-02 Cyclolab Ciklodextrin Kutato F Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption
DE19651055B4 (de) * 1996-12-09 2006-03-16 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Triazinderivaten und Dimethylisosorbid und deren Verwendung
GB9710521D0 (en) 1997-05-22 1997-07-16 Boots Co Plc Process
ES2171110B1 (es) * 2000-03-03 2003-06-16 Aplicaciones Farmacodinamicas Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.
ITMI20020986A1 (it) * 2002-05-10 2003-11-10 Acraf Composizione a base di diclofenac per il trattamento topico di affezioni del cavo orofaringeo
US20070042006A1 (en) * 2003-04-07 2007-02-22 Lau Kai K Stable carprofen composition
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
EP2522344A1 (en) 2006-03-28 2012-11-14 Javelin Pharmaceuticals, Inc. Formulations of Low Dose Diclofenac and Beta-Cyclodextrin
ES2347754B8 (es) * 2009-04-27 2012-06-04 Laboratorio De Aplicaciones Farmacodinamicas, S.A Suspension oral de lisinato de ibuprofeno
JP5977672B2 (ja) * 2009-04-27 2016-08-24 ラボラトリオ デ アプリカシオネス ファルマコディナミカス,エセ.アー.Laboratorio De Aplicaciones Farmacodinamicas,S.A. イブプロフェンリシナートの経口投与用の懸濁液
GB201021267D0 (en) 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation
KR20200094161A (ko) * 2017-11-30 2020-08-06 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 케토프로펜, 이의 염 및 거울상 이성질체의 안정한 액체 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
BE1000381A4 (fr) * 1987-03-13 1988-11-16 Pharlyse Sa Preparation pharmaceutique a base d'indometacine.
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica

Also Published As

Publication number Publication date
ES2034926T1 (es) 1993-04-16
IT1243342B (it) 1994-06-10
CA2066731A1 (en) 1992-01-14
WO1992000725A1 (en) 1992-01-23
AU8093591A (en) 1992-02-04
IT9020944A1 (it) 1992-01-13
IT9020944A0 (it) 1990-07-13
EP0491897A1 (en) 1992-07-01

Similar Documents

Publication Publication Date Title
DE4191166T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE4191771T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE4190939T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK17290D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR930300021T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK0449414T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE4190251T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE4192975T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE4191618T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK0465677T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE4190090T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE4193387T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0649163A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE4192352T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE4190412T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE4190330T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2658203B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2663808B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH0494382U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU631346B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ECSM90505U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ECSM90468U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ECSM90504U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ECSM90494U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ECSM90452U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)